OMOP Concept 741722
phenylbutyrate / taurursodiol Powder for Oral Suspension [Relyvrio]
StandardDrugRxNorm2613973Branded Drug Form
Maps from
0
Descendants
1
Valid from
3 Jan 2023
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(14)Roll up to these when you need a wider cohort.
- 1phenylbutyrate
- 1phenylbutyrate / taurursodiol Oral Powder Product
- 1phenylbutyrate / taurursodiol Oral Product
- 1Relyvrio Oral Powder Product
- 1Relyvrio Oral Product
- 1RELYVRIO - sodium phenylbutyrate/taurursodiol powder, for suspension
- 1sodium phenylbutyrate and ursodoxicoltaurine
- 1taurursodiol
- 2Oral Powder Product
- 2Oral Product
- 2Other nervous system drugs
- 3OTHER NERVOUS SYSTEM DRUGS
- 4OTHER NERVOUS SYSTEM DRUGS
- 5NERVOUS SYSTEM
Narrower concepts
(1)Included automatically when you query with descendants.
Get this concept via the API
Resolve phenylbutyrate / taurursodiol Powder for Oral Suspension [Relyvrio] - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/741722?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card